Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.

Polish journal of pathology : official journal of the Polish Society of Pathologists - 1 Jan 2020

Gülten Gülsün, Yalçın Nagİhan, Baltalarlı Bahar, Doğu Gamze, Acar Ferİdun, Doğruel Yücel

Abstract excerpt

Numerous genetic pathways associated with glioblastoma development have been identified. In this study, we investigated the prognostic significance of IDH1 and ATRX mutations and WT-1 and p53 expression in glioblastomas and that of surgical methods, radiotherapy and chemotherapy. 83 patients with glioblastomas were retrospectively evaluated. Immunohistochemical analysis was performed for IDH1, ATRX and WT-1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioblastoma
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to WT1 Proteins

Share to X-linked Nuclear Protein

Source

Identifiers

PMID: 32729303
DOI: 10.5114/pjp.2020.97020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.PMID 32729303Read ↗

Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient SurvivalSemantic proximity Read ↗

IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage responseSemantic proximity Read ↗

Omics-based integrated analysis identified ATRX as a biomarker associated with glioma diagnosis and prognosisSemantic proximity Read ↗

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas.Semantic proximity Read ↗

Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.Semantic proximity Read ↗

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.Semantic proximity Read ↗

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.Semantic proximity Read ↗

ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients.Semantic proximity Read ↗

New Clues in the Malignant Progression of Glioblastoma: Can the Thioredoxin System Play a Role?Semantic proximity Read ↗

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas.Semantic proximity Read ↗

Retrospective and Randomized Analysis of Influence and Correlation of Molecular and Clinical Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTRSemantic proximity Read ↗

PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.